SCHEMBL6798124

SCHEMBL6798124

COC(=O)[C@H](Cc1ccc(NS(=O)(=O)O)cc1)N(Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 18/20 0.51
PTPN2 P17706 1/20 0.48
PTPN1 P18031 1/20 0.48
PTPRA P18433 1/20 0.48
PTPN11 Q06124 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6795785 1.00 PTPRB (0.51) PTPRBPTPN2PTPN1PTPRAPTPN11
SCHEMBL6802812 0.90 PTPRB (0.48) PTPRBPTPN2PTPN1PTPRAPTPN11
SCHEMBL6802814 0.90 PTPRB (0.48) PTPRBPTPN2PTPN1PTPRAPTPN11
SCHEMBL6796473 0.81 PTPRB (0.53) PTPRBPTPN2PTPN1PTPRA
SCHEMBL6796461 0.81 PTPRB (0.53) PTPRBPTPN2PTPN1PTPRA
SCHEMBL6799990 0.81 ITGA4 (0.51)
SCHEMBL6799985 0.81 ITGA4 (0.51)
SCHEMBL7532982 0.78 ITGA4 (0.46)
SCHEMBL18359864 0.78 ALDH1A1 (0.48)
SCHEMBL8472423 0.78 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO claimed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US claimed
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE PTPRB 13/4885PTPN2 24/4885PTPN1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.